Research Management Group (RMG)

Funding Information Resources

This website is a resource for the Stanford University research community. Funding opportunity (internal and external, federal and non-federal) email announcements are distributed on an ongoing basis to various email distribution lists. The resources from the email announcements sent to Stanford faculty, research administrative staff, postdoctoral and medical fellows, graduate students (via their Ph.D. Program administrators) are posted to various webpages below.

Funding Opportunity email distribution lists: Stanford faculty and staff: please send an email to Jeanne Heschele at jheschele@stanford.edu to be added to a list.

Research Process Manager (RPM) and CT Contract Officer Department Assignments more >>

 

Links to Additional Funding Information Resources and Webpages
Federal Funding Opportunities

Funding opportunities arranged by topic

Miscellaneous



 

Recent Funding Opportunity Announcements:


Limited submission programs
Programs that limit the number of applicants and require an internal selection process
-limited NIH & NSF programs
-William T. Grant Foundation Scholars Program
-Brain Research Foundation Scientific Innovation Award( professors & assoc. prof.)
more >>

Upcoming distinguished achievement awards more >>
Global health funding opportunity updates more >>
NSF bioscience and engineering funding opportunities more >>
Biomedical, bioengineering, and engineering funding opportunties (EPA, DoE, misc. announcements) more >>
DoD funding opportunities more >>
Office of Naval Research RFPs more >>
Environmental Protection Agency (EPA) RFPs more >>
Foundation and association miscellaneous funding opportunities (10/02/13) more >>
Cardiovascular medicine (American Heart Association RFPs) more >>
Neuroscience funding opportunities more >>
Cancer funding opportunities more >>
Child heath funding opportunities more >>

 

Pfizer Center for Therapeutic Innovation (CTI)-Stanford University
Request for Translational Proposals for Biotherapeutic Targets
Spring 2014 Call for Proposals

CTI is looking for early-stage, large molecule projects related to Inflammation, autoimmunity, tissue remodeling, oncology, rare or genetic diseases, neuroscience, cardiovascular and metabolic diseases.
Eligibility: faculty with PI eligibility and CE faculty*
*CE faculty will need to submit a CE Faculty PI waiver request only if invited to submit a full proposal.
Internal pre-proposal deadline: Friday, May 23, 2014
Full proposals by invitation only.
Internal submission guidelines


Harrington Discovery Institute at University Hospitals Case Medical Center
2015 Harrington Scholar-Innovator Grant Program

The goal of the Harrington Scholar-Innovator Grant Program is to advance physician-scientist-initiated projects aimed at clinical introduction of new medicines (drugs or biologics). The specific focus of eligible projects includes fundamental discovery (elucidation of novel targets), novel drugs and biologics or drug-device combinations.
Letter of intent (required)*: Friday, May 2, 2014, 5 p.m. EDT
Full proposal (by invitation only): Aug. 1, 2014, 5 p.m., EDT
Guidelines >>
FAQ webpage >>

 

The Vilcek Foundation
The Vilcek Prize for Creative Promise in Biomedical Sciences

Unlimited numbers of applicants are permitted.
The Vilcek Foundation will award three cash prizes of $50,000 each to young foreign-born biomedical scientists who demonstrate outstanding early achievement. Eligible work may be in basic, applied, and/or translational biomedical science.
Eligibility: Stanford faculty with PI eligibility and CE faculty (with an approved CE faculty PI waiver)
Applicant must have been born outside of the United States. Individuals who were born in a U.S. territory (i.e., Guam, Puerto Rico) are not eligible;
Must be no more than 38 years old as of Dec. 31, 2014 (born on or after Jan. 1, 1976)
Applicant must be a naturalized citizen or permanent resident (green card holder) of the U.S.; earned a doctoral degree (M.D., Ph.D., or equivalent); intend to pursue a professional career in the U.S.; hold a full-time position in an academic institution or other organization.
Eligible positions include: Assistant or Associate Professors, Research Scientist or equivalent.
The applicant must be directly responsible for the design and execution of the work submitted for consideration.
Graduate students and postdoctoral fellows working under the supervision of a mentor are not eligible.
Deadline: June 10, 2014*
*Because this is a prize and not a sponsored project, you do not have to submit your applications through your institutional representative.
Guidelines: http://www.vilcek.org/prizes/creative-promise/biomedical-science.html


Patient-Centered Outcomes Research Institutes (PCORI)
Spring Cycle 2014 Funding Opportunities (PFAs)

1) Pragmatic Clinical Studies and Large Simple Trials to Evaluate Patient-Centered Outcomes
2) Effectiveness of Transitional Care
3) Obesity Treatment Options Set in Primary Care for Underserved Populations
4) Assessment of Prevention, Diagnosis, and Treatment Options
5) Improving Health Care Systems
6) Communication and Dissemination Research
7) Addressing Disparities
8) Improving Methods for Conducting Patient-Centered Outcomes Research
Timeline:
Spring Cycle Letter of intent (required): March 7, 2014
Full proposal (by invitation only)
Spring cycle 2014 RFP overview >>
Fall Cycle Letter of intent (required): September TBA
Fall 2014 program overview >>

 

2015 HHMI Investigator Competition
Unlimited numbers of applicants are permitted.
Eligibility: Stanford faculty with UTL appointments--basic researchers and physician scientists--who bring innovative approaches to the study of biological problems through biomedical disciplines, including plant biology, as well as adjacent fields of evolutionary biology, biophysics, chemical biology, biomedical engineering, and computational biology.
Deadline to establish eligibility: May 1, 2014* online
*
Individuals are encouraged to establish their eligibility by the above "soft" deadline. However, they may apply by the full application deadline (June 3), provided they meet the eligibility criteria.
Application Deadline: June 3, 2014, 3 p.m. ET (12 noon our time)
Program overview >>


Gordon and Betty Moore Foundation
Data-Driven Initiative Investigator Competition

Unlimited numbers of pre-applicants are permitted.
Eligibility: $1.5M funding opportunity for Stanford faculty with PI eligibility.
The foundation has a clear mandate to fund basic research in the natural sciences. The Data-Driven Discovery Initiative is interested in the intersection of these natural science domains with computer science and statistics/applied mathematics. This program does not fund disease-targeted research.
Pre-application (required)*: Feb. 24, 2014
Full proposals (by invitation only): mid-May 2014
Program overview >>



Simons Foundation
Simons Collaboration on the Origins of Life Investigator Award

Eligibility: faculty with UTL appointments
Unlimited #'s of applicants are permitted.
The deadline was Jan. 27, 2014
Guidelines
https://www.simonsfoundation.org/funding/funding-opportunities/life-sciences/collaboration-on-the-origins-of-life-investigator-award/

 

 

NIH Special announcements: $2.5M DP1 and $1.5M DP2 awards

Unlimited #'s of applicants are permitted for these DP1 and DP2 awards.

NIH Director's Pioneer Award (DP1) (RFA-RM-13-006)
$2.5M total direct costs plus indirects over 5 years (7 awards to be made each fiscal year)
Eligibility: faculty with PI eligibility
CORRECTION: Remaining Application Receipt Date(s): October 10, 2014, and October 9, 2015
Guidelines: http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-13-006.html
2013 recipients (including 1 from Stanford):
http://commonfund.nih.gov/pioneer/Recipients13


NIH Director's New Innovator Award Program (DP2) (RFA-RM-13-007)

$1.5M total direct costs plus indirects over 5 years (33 to be awarded each fiscal year)
Eligibility: assistant professors with PI eligibility who meet the NIH definition of early stage investigator (see the guidelines for details)
CORRECTION: Remaining Application Receipt Date(s): October, 17, 2014, and October 16, 2015
http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-13-007.html
2013 recipients (including 3 from Stanford) :
http://commonfund.nih.gov/newinnovator/Recipients13


NIDA Avant-Garde Award Program for HIV/AIDS and Drug Use Research (DP1) (RFA-DA-15-004)
$2.5M total direct costs plus indirects over 5 years (2-3 to be awarded)
Eligibility: faculty with PI eligibility
National Institute on Drug Abuse
Application Receipt Date(s): July 29, 2014, July 29, 2015, July 29, 2016
http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-15-004.html


NIDA Avenir Award Program for Research on Substance Abuse and HIV/AIDS (DP2) (RFA-DA-15-007)
$1.5M total direct costs plus indirects over 5 years (2-3 to be awarded)
Eligibility: assist. prof. with PI eligibility who meet the NIH definition of Early Stage Investigator (see the guidelines)
National Institute on Drug Abuse
Application Receipt Date(s): November 12, 2014, November 12, 2015, November 14, 2016
http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-15-007.html


NIDA Avenir Award Program for Genetics or Epigenetics of Substance Abuse (DP2) (RFA-DA-15-006)
$1.5M total direct costs plus indirects over 5 years (2-3 to be awarded)
Eligibility: assistant professors with PI eligibility who meet the definition of Early Stage Investigators (see the guidelines)
National Institute on Drug Abuse
Application Receipt Date(s): Aug. 18, 2014, Aug. 18, 2015, Aug. 18, 2016
http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-15-006.html

 
 
 

Department of Defense (DoD) Health Releated Funding Opportunities

 

DoD CDMRP-Congressionally Directed Medical Research Program
CDMRP synopsis of current programs more >>

ALS
,  Bone Marrow Failaure,  Breast Cancer,  Lung Cancer,  Ovarian Cancer

Institutional representative: you do not have to submit your pre-applications through your institutional representative (School of Medicine: RPM in RMG; or Other Schools: OSR Contract officer). You must submit your completed PDRF form and submit your full applications via Stanford's eSubmit system for your institutional representatives.

DoD CDMRP Amyotrophic Lateral Sclerosis Research Program

Download the program synopsis, guidelines, and application instructions from this wepbage:
http://cdmrp.army.mil/funding/alsrp.shtml

Therapeutic Development Award
Purpose: Supports preclinical assessment of therapeutics for ALS
Eligibility: faculty with PI eligibility and CE (with an approved CE faculty PI waiver)
Amount of funding: maximum of $1.5M direct costs plus indirects over 3 yrs.
Timeline:
Pre-application (required) deadline: May 13, 2014, 5pm p.m. ET via https://ebrap.org/
Invitation to submit a full proposal will be sent in June.
Full proposal (by invitation only): Aug. 20, 2014, 11:59 p.m. ET via grantsgov

Therapeutic Idea Award
Amount of funding: maximum of $400,000 direct costs plus indirects over 2 yrs.
Purpose: to promote new ideas that are still in the early stages of development with the potential to yield highly impactful data and new avenues of investigation for novel therapeutics for ALS treatment.
Eligibility: faculty with PI eligibility and CE (with an approved CE faculty PI waiver).
Stanford eligibility clarification: although it states investigators at all academic levels are eligible, because this is a research grant and not a mentored career development grant, Stanford PIship policy only permits faculty with PI eligibility to apply.
Timeline:
Pre-application (required) deadline: May 13, 2014, 5pm p.m. ET via https://ebrap.org/
Invitation to submit a full proposal will be sent in June.
Full proposal (by invitation only): Aug. 20, 2014, 11:59 p.m. ET via grantsgov

DoD CDMRP Bone Marrow Failure Research Program (BMFRP)

Download the program synopsis, guidelines, and application instructions from this wepbage:
http://cdmrp.army.mil/funding/bmfrp.shtml

Idea Development Award

Amount of funding: maximum of $400,000 direct costs plus indirects over 3 years
Purpose: this award mechanism is designed to support new ideas and to move toward the BMFRP vision of understanding and curing BMF diseases. (see the guidelines for additional information)
Eligibility: faculty with PI eligibility and CE (with an approved CE faculty PI waiver).
Timeline:
Pre-application (required) deadline: May 13, 2014, 5pm p.m. ET via https://ebrap.org/
Invitation to submit a full proposal will be sent in June.
Full proposal (by invitation only): Aug. 28, 2014, 11:59 p.m. ET via grantsgov

DoD CDMRP Breast Cancer Research Program (BCRP)

PLEASE READ: see the Stanford eligibility clarification comments below prior to reading the guidelines: http://cdmrp.army.mil/funding/bcrp.shtml

BCRP Award Mechanisms

ERA of Hope Scholar Award
Amount of funding: maximum of $2.5 million direct costs plus indirects over 5 years
Timeline:
Pre-application (required) deadline: August 1, 2014, 5pm p.m. ET via https://ebrap.org/
Full proposal: Aug. 15, 2014, 11:59 p.m. ET via grantsgov
Eligibility: assistant professors with PI eligibility who are within 6 years of their last training position (e.g., postdoctoral fellowship; medical residency; clinical fellowship) as of the Aug. 1, 2014, application deadline.
Purpose: The Era of Hope Scholar Award supports individuals who are early in their careers and have demonstrated significant potential for innovation in breast cancer research. Experience in breast cancer research is not required; however, the application must focus on breast cancer, and the PI must maintain a 50% dedication of his/her full-time professional effort during the award period to breast cancer research. This professional effort in breast cancer research can be through a combination of this award and other current support. Individuals from other disciplines who will apply novel concepts to breast cancer are encouraged to submit.


Innovator Award
Amount of funding: maximum of $5 million direct costs plus indirects over 5 years
Eligibility: associate professors and professors with PI eligibility
Timeline:
Pre-application (nomination) (required) deadline: May 14, 2014, 5pm p.m. ET via https://ebrap.org/
Invitation to submit an application: June
Full proposal (by invitation only): Aug. 15, 2014, 11:59 p.m. ET via grantsgov
Purpose: The Innovator Award supports visionary individuals who have demonstrated creativity, innovative work, and leadership in any field including, but not limited to, breast cancer. The Innovator Award will provide these individuals with the funding and freedom to pursue their most novel, visionary, high-risk ideas that could ultimately lead to ending breast cancer. Experience in breast cancer research is not required; however, the application must focus on breast cancer, and the PI must maintain a 50% dedication of his/her full-time professional effort during the award period to breast cancer research.
This professional effort in breast cancer research can be through a combination of this award and other current support. Individuals from other disciplines who will apply novel concepts to breast cancer are encouraged to submit.



Breakthrough Award Levels 1 and 2
Amount of funding and funding level descriptions:
Funding level 1: maximum of $350,000 direct costs plus indirects over 3 years: Innovative, high-risk/high-reward research that is in the earliest stages of idea development. Research with potential to yield new avenues of investigation. Proof of concept. No preliminary data required.
Funding level 2: maximum of $700,00 direct costs plus indirects over 3 years/. Research that is already supported by preliminary data and has potential to make significant advancements toward clinical translation. Demonstration of efficacy in in vivo models, as applicable.
Timeline:
Pre-application (required) deadline: May 14, 2014, 5pm p.m. ET via https://ebrap.org/
Full proposal: May 28, 2014, 11:59 p.m. ET via grantsgov
Purpose: The intent of the Breakthrough Award is to support promising research that has high potential to lead to or make breakthroughs in breast cancer.
Eligibility: Faculty with PI eligibility and CE faculty (with an approved CE faculty waiver), Instructors* and Postdoctoral Fellows*
Stanford eligibility clarification for this RFP: The eligibility guidelines indicate "Investigators at all academic levels (or equivalent) are eligible to submit an application." and Postdoctoral fellows are eligible to submit and are encouraged to apply. Because the RFP is considered a mentored career development grant for postdoctoral fellows, our Dean's Office has confirmed this can also be considered mentored career development grant for Instructors as well.
Instructors and Postdoctoral fellows will need to submit career development PI waivers to their RPMs in RMG in order to apply.
Partnering PI Option: The Breakthrough Award encourages applications that include meaningful and productive collaborations between investigators. The Partnering PI Option is structured to accommodate two PIs, called the Initiating PI and the Partnering PI, each of whom will receive a separate award.

Breakthrough Award Levels 3 and 4
Amount of funding and funding level descriptions:
Funding level 3: maximum of $2.5M direct costs plus indirects over 5 years. Advanced translational studies that have potential for near-term clinical investigation. Small-scale clinical trials may apply.
Funding level 4: maximum of $10M direct costs plus indirects over 5 years. Large-scale projects that will transform and revolutionize the clinical management and/or prevention of breast cancer. Near-term clinical impact is expected. PIs are expected to have experience in successfully leading large-scale projects
Timeline:
Pre-application (required) deadline: May 14, 2014, 5pm p.m. ET via https://ebrap.org/
Full proposal (by invitation only): August 15, 2014, 11:59 p.m. ET via grantsgov
Purpose: The intent of the Breakthrough Award is to support promising research that has high potential to lead to or make breakthroughs in breast cancer.
Eligibility:
Stanford faculty with PI eligibility and CE faculty (with an approved PI waiver)
Stanford eligibility clarification for this RFP: Even though the guidelines state "Investigators at all academic levels (or equivalent) are eligible to submit an application", because this is a research grant and not a mentored career development award, Stanford PI ship policy only permits faculty with PI eligibility to apply. Therefore, Instructors and postdoctoral fellows are not eligible to request a career development PI waiver in order to apply for this particular RFP.
Partnering PI Option: The Breakthrough Award encourages applications that include meaningful and productive collaborations between investigators. The Partnering PI Option is structured to accommodate two PIs, called the Initiating PI and the Partnering PI, each of whom will each receive a separate award.
Note: An invited oral presentation to the BCRP Integration Panel (IP) is a requirement for application review of Funding Level 4 projects, as described in Section II.C., Application Submission Content and Forms.
Partnering PI Option: The combined total funding for the Initiating PI and Partnering PI may not exceed the maximum allowable direct costs for the selected funding level. No additional funds will be provided. A separate award will be made to each PI’s organization.

DoD Congressionally Directed Medical Research Program (CDMRP)
Lung Cancer Research Program (LCRP)

Guidelines:
Download the program synopsis, guidelines, and application instructions from the following wepbage. PLEASE READ: see the Stanford eligibility clarification comments in this email prior to reading the guidelines. http://cdmrp.army.mil/funding/lcrp.shtml

LCRP Areas of Emphasis
To be considered for funding, applications must address at least one of the seven Areas of Emphasis listed below:
• Identify or develop noninvasive or minimally invasive tools to improve detection of the initial stages of lung cancer.
• Identify, develop, and/or build upon already existing tools for screening or early detection of lung cancer. Screening may include, but is not limited to, computed tomography scans, X-rays, imaging biomarkers, genetics/genomics/proteomics/ metabolomics/transcriptomics, and assessment of risk factors.
• Understand the molecular mechanisms of progression to clinically significant lung cancer.
• Understand the molecular mechanisms that lead to various subtypes of lung cancer.
• Identify innovative strategies for prevention and treatment of early and/or localized lung cancer.
• Understand predictive and prognostic markers to identify responders and nonresponders.
• Understand susceptibility or resistance to treatment.

Award Mechanisms

Career Development Award
Amount of funding: maximum of $240,000 total direct costs plus indirects over 2 years
Timeline:
Pre-application (required) deadline: June 3, 2014, 5pm p.m. ET via https://ebrap.org/
Full proposal: Sept. 17, 2014, 11:59 p.m. ET via grantsgov
Purpose: The Career Development Award supports early-career, independent investigators to conduct impactful research under the mentorship of an experienced lung cancer researcher as an opportunity to obtain the funding, mentoring, and experience necessary for productive, independent careers at the forefront of lung cancer research. This award is intended to support impactful research projects with an emphasis on discovery.
Submissions from and partnerships with investigators at Military Treatment Facilities (MTFs), military labs, the Department of Veterans Affairs (VA) Medical Centers and research laboratories are strongly encouraged.
Eligibility: assistant professors with PI eligibility and CE assistant professors (with an approved CE Faculty PI waiver) who are within the first five years of their first faculty appointment. (You must also count the years you spent in a faculty position at another institution prior to coming to Stanford.edu.)
Stanford eligibility clarification: Instructors are not eligible because their positions are not faculty positions and they are not considered "Independent" researchers.
Applicants: must not have received more than $300,000 in total direct costs for previous or concurrent lung cancer research as PI of one or more federally or privately funded, non-mentored, peer-reviewed grants.
Your Mentor: be at or above the level of associate professor and have a proven publication and funding record in lung cancer research.


Clinical Exploration Award
Amount of funding:
Clinical Trials: maximum of $430,000 direct costs plus indirects over 3 years
Correlative studies: maximum of $250,000 direct costs plus indirects over 2 years
Eligibility: faculty with PI eligibility and CE faculty (with an approved CE Faculty PI waiver)
Timeline:
Pre-application (required) deadline:
June 3, 2014, 5pm p.m. ET via https://ebrap.org/
Full proposal: Sept. 17, 2014, 11:59 p.m. ET via grantsgov
Purpose: This award mechanism supports early-phase, proof-of-principle clinical trials and correlative studies to investigate hypothesis-based, innovative interventions that have the potential to resolve current clinical barriers and result in a profound impact on the clinical management of lung cancer. While therapeutic approaches proposed for testing through the CEA must represent novel, hypothesis-based, “outside-the-box” approaches for treating lung cancer, they may include therapies already in clinical use, or undergoing clinical testing, for other diseases, provided that the proposed use for lung cancer would lead to a major advancement for treating the disease. It is anticipated that outcomes from studies funded by this award will provide scientific rationale for subsequent development of larger, efficacy-based clinical trials of interventions that will transform lung cancer clinical care.
Submissions from and partnerships with investigators at Military Treatment Facilities (MTFs), military labs, the Department of Veterans Affairs (VA) Medical Centers and research laboratories are strongly encouraged.


Idea Development Award
Amount of funding: maximum of $350,000 in direct costs plus indirects over 2 years
Timeline:
Pre-application (required) deadline: June 3, 2014, 5pm p.m. ET via https://ebrap.org/
Full proposal: Sept. 17, 2014, 11:59 p.m. ET via grantsgov
Purpose: The Idea Development Award promotes new ideas that are still in the early stages of development and have the potential to yield impactful data and new avenues of investigation. This award supports conceptually innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress toward eradicating deaths from lung cancer. Applications should include a well-formulated, testable hypothesis based on strong scientific rationale.
Submissions from and partnerships with investigators at Military Treatment Facilities (MTFs), military labs, the Department of Veterans Affairs (VA) Medical Centers and research laboratories are strongly encouraged.
Eligibility:
Established investigators: faculty with PI eligibility and CE faculty (with an approved CE Faculty PI waiver)
New Investigators: faculty with PI eligibility and CE faculty (with an approved CE Faculty PI waiver) who, as of the application deadline (Sept. 17, 2014) must be within 10 years of first faculty appointment (include time spent in faculty positions at another institution prior to coming to Stanford). Also-as of the application submission (Sept. 17, 2014) deadline date they must not have previously received a LCRP Idea Development Award or LCRP Early Investigator Synergistic Idea Award.

DoD Congressionally Directed Medical Research Program (CDMRP)
Ovarian Cancer Research Program (OCRP)

Guidelines:
Download the program synopsis, guidelines, and application instructions from the following wepbage. PLEASE READ: see the Stanford eligibility clarification comments in this email prior to reading the guidelines. http://cdmrp.army.mil/funding/ocrp.shtml

The overall goal of the FY14 OCRP is to eliminate ovarian cancer by supporting innovative, high-impact research. The OCRP’s long-term priorities are:
Understand precursor lesion/stem cell, microenvironment, and pathogenesis/ progression of all types of ovarian cancer including rare subtypes;
Develop or improve performance and reliability of screening, diagnostic approaches, and treatment;
Develop and validate models to study initiation and progression of ovarian cancer;
Address issues in primary prevention and survivorship;
Investigate tumor response to therapy including tumor survival, dormancy, cell death, clonal evolution, tumor heterogeneity; and
Enhance the pool of ovarian cancer scientists.

Award Mechanisms

Clinical Translational Leverage Award
Amount of funding: maximum of $250,000 direct costs plus indirects over 2 years
Timeline:
Pre-application (required) deadline: June 3, 2014, 5pm p.m. ET via https://ebrap.org/
Full proposal: August 27, 2014, 11:59 p.m. ET via grantsgov
Purpose: The intent of the OCRP Clinical Translational Leverage Award mechanism is to support leveraging of human-based ovarian cancer resources in translational research. This award supports early-phase, proof-of-principle clinical trials and correlative studies (retrospective and prospective) to investigate high-impact research ideas or unmet needs in ovarian cancer. Preliminary data are required. Funding from the Clinical Translational Leverage Award must support a clinical trial or a correlative study associated with an ongoing or completed clinical trial.
Eligibility: faculty with PI eligibility and CE (faculty with an approved CE faculty PI waiver)

Investigator-Initiated Research Award
Amount of funding: maximum of $450,000 direct costs plus indirects over 3 years
Timeline:
Pre-application (required) deadline: June 3, 2014, 5pm p.m. ET via https://ebrap.org/
Full proposal: August 27, 2014, 11:59 p.m. ET via grantsgov
Purpose: The OCRP Investigator-Initiated Research Award is intended to support studies that will significantly impact ovarian cancer research and/or patient care. Research projects may focus on any phase of research from basic laboratory research through translational research. The rationale for a research idea may be derived from a laboratory discovery, population-based studies, a clinician’s first-hand knowledge of patients, or anecdotal data. Applications must include preliminary data that are relevant to ovarian cancer and support the proposed research project. Research involving human subjects and human anatomical substances is permitted; however, this award may not be used to conduct clinical trials.
Eligibility: faculty with PI eligibility and CE (faculty with an approved CE faculty PI waiver)

Ovarian Cancer Academy Dean and Assistant Dean ( Leadership) Awards
Amount of funding: the combined total funding may not exceed $1.2 million total direct costs plus indirects over 5 years
Note: The Ovarian Cancer Academy Dean and Assistant Dean (Leadership) award is structured to support two PIs; the Academy Dean and Assistant Dean will each receive a separate award. The two PIs are expected to be partners in the Academy Leadership, and direct cost funding should reflect their roles.
Timeline:
Pre-application (required) deadline: June 3, 2014, 5pm p.m. ET via https://ebrap.org/
Full proposal: August 27, 2014, 11:59 p.m. ET via grantsgov
Purpose: This FY14 Funding Opportunity is soliciting applications for an Academy Dean and Assistant Dean to lead the Ovarian Cancer Academy starting no later than October 2015.
Eligibility: faculty with PI eligibility who are established ovarian cancer researchers with ovarian cancer research funding, and have a record of ovarian cancer publications in peer reviewed journals. See the guidelines for additional information. Note: Designated Mentors on FY14 Ovarian Cancer Academy Early-Career Investigator applications and Designated Mentors of current Ovarian Cancer Academy Early-Career Investigators are eligible to apply for this award.
Responsibilities of the Academy Leadership include, but are not limited to:
-Act as a resource for all Early-Career Investigators and Designated Mentors in the Academy over the 5-year period of performance as Academy Leadership.
-Facilitate communication and collaboration among all of the Early-Career Investigators and -Designated Mentors (including periodic interactive communication among all Academy members).
-Develop assessment criteria to evaluate the research progress made by all of the Early-Career -Investigators, as well as their career progression and sustainment as independent investigators in ovarian cancer research.
-Provide constructive critiques with the goal of advancing the research and professional careers of the Early-Career Investigators and strengthening the mentorship of the Designated Mentors.
-Provide avenues to increase the visibility of Early-Career Investigators within the ovarian cancer research and advocacy communities (e.g., peer review, conferences, editorial boards).
-Support the professional development of the Early-Career Investigators into leading researchers through invited presentations by experts outside of the Ovarian Cancer Academy.
-Plan and host an annual 1-day and biennially, a multi-day workshop for all Early-Career -Investigator/Designated Mentor pairs to present their research, share knowledge, and develop collaborative efforts within the Ovarian Cancer Academy.

Ovarian Cancer Academy Award-Early Career Investigator
Amount of funding: maximum of $750,000 direct costs plus indirects over 5 years
Timeline:
Pre-application (required) deadline: June 3, 2014, 5pm p.m. ET via https://ebrap.org/
Full proposal: August 27, 2014, 11:59 p.m. ET via grantsgov
Purpose: This FY14 Program Announcement/Funding Opportunity is soliciting additional Early-Career Investigators to join the existing Academy. Applications to this award mechanism must be submitted by the Early-Career Investigator as the Principal Investigator (PI). Preliminary data to support the feasibility of the research hypotheses and research approaches are required; however, these data do not necessarily need to be derived from the ovarian cancer research field. Clinical trials are not allowed under this mechanism. This award provides the Early-Career Investigator with funding, networking opportunities, and research experience necessary to develop and sustain a successful, independent career at the forefront of ovarian cancer research. This award also provides support and protected time for the Early-Career Investigator for 5 years of intensive research under the guidance of a Designated Mentor experienced in ovarian cancer research.
Eligibility: assistant professors with PI eligibility and CE assistant professors (with an approved CE faculty PI waiver) are within the first 3 years of his/her first faculty position at the time of submission (as of Aug. 27, 2014) (note: you must include time spent in a faculty position at another instution prior to coming to Stanford). Applicants may be research or physician-scientist, must have an institutional commitment of at least 50% protected time, and must commit no less than 25% effort to this award.
Designated Mentor: faculty with PI eligibility who are established ovarian cancer researchers with ovarian cancer research funding, and have a record of ovarian cancer publications in peer reviewed journals. See the guidelines for additional criteria. In addition to being a Designated Mentor to an Early-Career Investigator at his/her institution, the Designated Mentor must agree to serve as a secondary Mentor to another Ovarian Cancer Academy Early-Career Investigator who may or may not be at the Designated Mentor’s institution.



 

 

 

 

 

 

 

 

Department of Defense-Department of the Army Material Command
United States Army Research Institute for the Behavioral and Social Sciences Broad Agency Announcement for Basic, Applied, and Advanced Scientific Research (FY13-18)

W911NF-13-R-0001
The funding opportunity is divided into two sections-
(1) Basic Research and
(2) Applied Research and Advanced Technology Development.
The four major topic areas of research interest include the following:
(1) Training (2) Leader Development (3) Team and Inter-Organizational Performance in Complex Environments (4) Solider/Personnel Issues.
Timeline: white papers and applications will be accepted up until and including: Feb. 5, 2018
Go to grantsgov search page and enter "W911NF-13-R-0001" under Funding Opp #. Then click on the full announcement link to download the guidelines
http://www.grants.gov/web/grants/search-grants.html

Department of Defense (DoD)
DoD United States Army Medical Research and Materiel Command (USAMRMC)
Broad Agency Announcement for Extramural Medical Research W81XWH-BAA-14-1

See the nine research areas of interest and related topics in the guidelines
Military infectious disease program, combat casualty care research program, militerary operational medicine research program, clinical and rehabilitative medicine research program, medical biologic defense research program, medical chemical defense research program, medical training and health information sciences research program, radiation health effects research program, special investment areas/innovation funding
Timeline:
Pre-proposal/pre-applications are encouraged and may be submitted online at any time prior to the BAA closing date
Full proposals: Invited full proposal/applications should be submitted within 90 days of the invitation via grants.gov
BAA closing date: Sept. 30, 2014
Go to grantsgov search page and enter "W81XWH-BAA-14-1" under Funding Opp #. Then click on the full announcement link to download the guidelines
http://www.grants.gov/web/grants/search-grants.html

 

 

DoD Office of Naval Research

 

 

DoD ONR Department of the Navy Science and Technology
Long Range Broad Agency Announcement (BAA) ONRBAA14-001

This BAA is intended for proposals related to basic research, applied research, or advanced technology development.
Topic areas (see the guidelines for additional details): Expeditionary Maneuver Warfare & Combating Terrorism Department; Command, Control, Communications, Computers, Intelligence, Surveillance, and Reconnaissance; Ocean Battlespace Sensing; The Sea Warfare and Weapons Department; Warfighter Performance; Naval Air Warfare and Weapons; The Marine Corps Warfighting Lab
Eligibility: Stanford faculty with PI eligibility
Amount of funding: The amount and period of performance of each selected proposal may vary depending on the research area and the technical approach to be pursued by the selected offeror.
Note: the guidelines indicate: "Prior to preparing proposals, potential offerors are strongly encouraged to contact the ONR point of contact (POC). To identify the POC, follow the link for the appropriate code or division listed below (at the top of page 4) and then click on the link to the thrust or topic area. Each thrust or topic area will provide a POC or e-mail address."
Proposals for any of the various topics for this full BAA below (#2) can be submitted anytime prior to Sept. 30, 2014. However, you may want to consider submitting a White paper first. It all cases they encourage PIs to contact the "Point of Contact for the various topic areas to discuss your proposal.
White paper submissions: submit any time. See white paper instructions on pages 22-24 in the guidelines.
Full proposal deadline: Proposals may be submitted at any time via grantsgov before the BAA closing date.
BAA Closing date: Sept. 30, 2014
Guidelines- PDF file attached: File name: 2.DoD_ONR_BAA.pdf  pdf

 

Department of Energy (DoE)


 

Environmental Protection Agency (EPA)

 

 

 

Federal Drug Administration (FDA)


FDA Broad Agency Announcement (BAA) for the Advanced Research and Development of Regulatory Science FDABAA-13-00119

Guidelines more >>
Timeline:
Stage 1: Quad Chart and White Paper deadline: Anytime during the open period.
Stage 2: Full proposal: within 30 days of invitation (unless otherwise designated)
Program period ends: May 22, 2014
Amount of funding: Anticipated funding for the program (not per contract or award) may range from $200,000 to $50,000,000 dollars subject to congressional appropriations. This funding profile is an estimate only and will not be a contractual obligation for funding. All funding is subject to change due to government discretion and availability.
Eligibility: Faculty with PI eligibility (with UTL, MCL, and NTL-Research appoints) and CE faculty (with an approved PI waiver)
The BAA is open to all responsible sources. Offerors may include single entities or teams from private sector organizations, Federally Funded Research and Development Centers (FFRDCs), and academic institutions.
Purpose: The purpose of this BAA is to solicit proposals that focus on one or more of the following areas of interest.
Areas of interest: For detailed descriptions, see pages 5-13 of the program guidelines.
1. Modernize Toxicology to Enhance Product Safety; 2. Stimulate Innovation in Clinical Evaluations and Personalized Medicine to Improve Product Development and Patient Outcomes; 3. Support New Approaches to Improve Product Manufacturing and Quality; 4. Ensure FDA Readiness to Evaluate Innovative Emerging Technologies; 5. Harness Diverse Data through Information Sciences to Improve Health Outcomes; 6. Implement a New Prevention-Focused Food Safety System to Protect Public Health
7. Facilitate Development of Medical Countermeasures to Protect Against Threats to U.S. and Global Health and Security; 8. Strengthening Social and Behavioral Science at FDA by Enhancing Audience Understanding; 9. Strengthening the Global Product Safety Net

 


NIH Resources

CIRM: California Institute for Regenerative Medicine

CIRM Home page  more>>

 

Current funding opportunities


CIRM 13-04 External Innovation Pilot Program

The objective of this RFA is to catalyze the collaboration between California researchers and researchers external to California. This program would provide funding for key personnel in California to join innovative external studies in order to accelerate those studies towards clinical applications.
Eligibility: faculty with PI eligibility (see the guidelines for project and PI eligibility criteria)
Amount of funding: up to $500K direct costs per year for 12-36 months

This RFA is targeted at only the most exceptional proposals. CIRM expects to support only one or two such projects per year.
Deadline: Letters of intent accepted anytime via their online grants management portal
Full proposal (by invitation only)

Guidelines/overview webpage >>

 

 


Search CIRM-funded projects >>

 



Foundation Relations and Funding

Please see specific requests for foundation funding on the calendar webpage
or in the recent announcements above >>


Clearance for Restricted Foundations
(see list of foundations which require central university Foundation Relation approval) more >>


Foundation Relations: MCD and LPFCH
: assistance with your proposals
The Foundation Relations team in the Medical Center Development office is available to assist School of Medicine faculty with a review and editing of your proposal. This office facilitates mutually beneficial relationships between faculty and private and philanthropic organizations. Some foundations state on their websites that they do not accept unsolicited requests for funding.   Please contact Joy Morimoto at 650-736-9749, joym@stanford.edu, or Michelle Heeseman at 650-736-8968, Heeseman@stanford.edu, for assistance.

Children's health: For assistance with proposals in children’s health research, please contact Ann Rose ann.rose@lpfch.org 650-497-8444 or Edna Neivert Edna.Neivert@LPFCH.ORG 650-724-2783 in Foundation Relations at Lucile Packard Foundation for Children’s Health.



Miscellaneous Federal Agency Funding Resources

Grants.Gov Funding Opportunity Search more>>


Center for Disease Control and Prevention (CDC)

Funding Opportunities »


DARPA Programs

Current Funding Opportunities »
Defense Sciences Office (DSO) »
Information Processing Techniques Office (IPTO) »
Microsystems Technology Office (MTO) »
Strategic Technology Office (STO) »
Tactical Technology Office (TTO) »

Department of Defense (DoD)
Congressionally Directed Medical Research Program ( CDMRP)

DoD CDMRP Summary of Current Funding Opportunities webpage>>
   
Summary of all current funding mechanisms

Environmental Protection Agency (EPA)
Funding opportunities »


Health Resources and Services Administration (HRSA):
Current funding opportunities »


NASA
[includes National Space Biomedical Research Institute (NSBRI)]
Open solicitations »


Office of Naval Research

Contracts & Grants — Broad Agency Announcements (BAAs) »

U.S. Army Medical Research Acquisition Activity (USAMRAA) 
Program Announcement webpage »



Howard Hughes Medical Institute (HHMI)

HHMI International Research Student Fellowship
Internal selection process is already underway-the end of October through November
Guidelines


2015 HHMI Investigator Competition
Eligibility: Stanford faculty with UTL appointments--basic researchers and physician scientists--who bring innovative approaches to the study of biological problems through biomedical disciplines, including plant biology, as well as adjacent fields of evolutionary biology, biophysics, chemical biology, biomedical engineering, and computational biology.
Deadline to established eligibility
(required): May 1, 2014 online
Application Deadline: June 3, 2014, 3 p.m. ET (12 noon our time)
Program overview >>

 

 

HHMI Medical Fellows Program
Overview: more >>

Spend a year—or a summer—conducting full-time basic, translational, or applied biomedical research.
The Year-Long Program gives you the flexibility to select your mentor and project from laboratories throughout the United States, including those of HHMI investigators and early career scientists, or be matched with a mentor at HHMI's Janelia Farm Research Campus near Washington, D.C.
See guidelines for eligibility
Deadline: Jan. TBA
more >>
The Summer Program offers you exceptional research training in the laboratory of an HHMI investigator, early career scientist, or a Janelia Farm researcher
See the guidelines for eligibility
Deadline: Feb. TBA
more >>
Before you finalize your plans for medical residency or postgraduate training, take some time to experience the excitement and intellectual rewards of biomedical research. Your experience could make an impact in medicine and your future career.



Information on HHMI Programs not currently offering funding opportunities:
Science Education Grants » for Institutions (note: an internal selection process will be required when these are announced)
Research Grants for Individuals »
Scientific competitons webpage>>


Stanford Resources

 

    • Who can be a Principal Investigator (PI)? Stanford's PI Eligibility and PI Waiver Policy more >>
    • Institutional Representatives:
      • School of Medicine: Research Process Managers (RPM) in the Research Management Group (RMG)  more >>
      • Other schools: Download the Pre-award OSR department assignments on this new DoResearch webpage >>
    • Center Grants Coordinator, Pam Jahnke, Office of the Vice Provost and Dean of Research, more >>
      Foundation Relations and Funding see below >>
    • DoResearch website (Research policies, procedures, funding) more >>
    • School of Medicine Research Administrative resources (RMG webpage) more >>
    • Office of International Affairs (considerations and regulations associated with international research or travel) more >>
    • Shared Facility/Service Center Resource: Bruce Koch, Senior Director, Discovery and Technological Service Centers, Office of the Senior Associate Dean for Research at bruce.koch@stanford.edu.
      School of Medicine Spectrum webpage "Enabling Technologies" (includes links to shared facilities) more >>
      School of Medicine Service Centers links more >>
      DoResearch Shared Facility webpage more >>

Top

Stanford Medicine Resources:

Footer Links: